Literature DB >> 33271439

Building ubiquitination machineries: E3 ligase multi-subunit assembly and substrate targeting by PROTACs and molecular glues.

Sarath Ramachandran1, Alessio Ciulli2.   

Abstract

E3 ubiquitin ligase machineries are emerging as attractive therapeutic targets because they confer specificity to substrate ubiquitination and can be hijacked for targeted protein degradation. In this review, we bring to focus our current structural understanding of E3 ligase complexes, in particular the multi-subunit cullin RING ligases, and modulation thereof by small-molecule glues and PROTAC degraders. We highlight recent advances in elucidating the modular assembly of E3 ligase machineries, their diverse substrate and degron recognition mechanisms, and how these structural features impact on ligase function. We then outline the emergence of structures of E3 ligases bound to neo-substrates and degrader molecules, and highlight the importance of studying such ternary complexes for structure-based degrader design.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 33271439     DOI: 10.1016/j.sbi.2020.10.009

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  5 in total

1.  A review on cullin neddylation and strategies to identify its inhibitors for cancer therapy.

Authors:  Iqra Bano; Moolchand Malhi; Min Zhao; Liviu Giurgiulescu; Hira Sajjad; Marek Kieliszek
Journal:  3 Biotech       Date:  2022-03-29       Impact factor: 2.406

2.  Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity.

Authors:  Dongwen Lv; Pratik Pal; Xingui Liu; Yannan Jia; Dinesh Thummuri; Peiyi Zhang; Wanyi Hu; Jing Pei; Qi Zhang; Shuo Zhou; Sajid Khan; Xuan Zhang; Nan Hua; Qingping Yang; Sebastian Arango; Weizhou Zhang; Digant Nayak; Shaun K Olsen; Susan T Weintraub; Robert Hromas; Marina Konopleva; Yaxia Yuan; Guangrong Zheng; Daohong Zhou
Journal:  Nat Commun       Date:  2021-11-25       Impact factor: 14.919

3.  Are we ready to design oral PROTACs®?

Authors:  Diego Garcia Jimenez; Matteo Rossi Sebastiano; Giulia Caron; Giuseppe Ermondi
Journal:  ADMET DMPK       Date:  2021-08-31

Review 4.  PROTAC targeted protein degraders: the past is prologue.

Authors:  Miklós Békés; David R Langley; Craig M Crews
Journal:  Nat Rev Drug Discov       Date:  2022-01-18       Impact factor: 112.288

Review 5.  Unifying Catalysis Framework to Dissect Proteasomal Degradation Paradigms.

Authors:  Frances P Rodriguez-Rivera; Samuel M Levi
Journal:  ACS Cent Sci       Date:  2021-06-16       Impact factor: 14.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.